Medtronic Plc (MDT)

111.20
1.20 1.10
NYSE : Health Technology
Prev Close 110.00
Open 110.33
Day Low/High 110.13 / 111.73
52 Wk Low/High 81.66 / 111.24
Volume 1.17M
Avg Volume 4.44M
Exchange NYSE
Shares Outstanding 1.34B
Market Cap 146.70B
EPS 3.40
P/E Ratio 33.23
Div & Yield 2.16 (1.87%)

Latest News

Medtronic Hits Our Price Target: Time to Take Profits?

Medtronic Hits Our Price Target: Time to Take Profits?

A follow-up to our story in June.

National Osteoporosis Foundation Supports New Evidence-Based Care Pathway Designed To Optimize Care For Vertebral Compression Fractures (VCF)

National Osteoporosis Foundation Supports New Evidence-Based Care Pathway Designed To Optimize Care For Vertebral Compression Fractures (VCF)

Pathway Helps Physicians Better Identify Which Patients to Treat with Vertebral Augmentation, Which to Manage with Conservative Care

Medtronic And Novo Nordisk Enter Agreement To Provide Integrated Digital Solutions For People With Diabetes

Medtronic And Novo Nordisk Enter Agreement To Provide Integrated Digital Solutions For People With Diabetes

The New Collaboration Aims to Develop Solutions Enabling Dosing Data from Novo Nordisk Smart Insulin Pens to be Shared with Medtronic Continuous Glucose Monitoring Devices

Medtronic Named A Leading Sustainability Company

Medtronic Named A Leading Sustainability Company

Strong ESG Practices Results in Inclusion on North American Dow Jones Sustainability Index (DJSI) for Twelfth Consecutive Year

Medtronic Announces Reimbursement In Germany For MiniMed™ 670G Insulin Pump System For Individuals With Type 1 Diabetes

Medtronic Announces Reimbursement In Germany For MiniMed™ 670G Insulin Pump System For Individuals With Type 1 Diabetes

DUBLIN, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it has secured reimbursement for the MiniMed™ 670G insulin pump system with the German Federal...

IN.PACT AV Access Trial Meets Primary Safety And Effectiveness Endpoints

IN.PACT AV Access Trial Meets Primary Safety And Effectiveness Endpoints

IN.PACT AV Drug-Coated Balloon Shows Promise in Treating Arteriovenous Fistulae Lesions in End-Stage Renal Disease Patients

Correction: Medtronic EVP & CFO Karen L. Parkhill To Speak At Morgan Stanley Global Healthcare Conference

Correction: Medtronic EVP & CFO Karen L. Parkhill To Speak At Morgan Stanley Global Healthcare Conference

The press release published today at 11:00 a.m.

Medtronic EVP & CFO Karen L. Parkhill To Speak At Morgan Stanley Global Healthcare Conference

Medtronic EVP & CFO Karen L. Parkhill To Speak At Morgan Stanley Global Healthcare Conference

DUBLIN, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10, 2019, in New York...

Medtronic EVP & CVG President Mike Coyle To Speak At Wells Fargo Securities Healthcare Conference

Medtronic EVP & CVG President Mike Coyle To Speak At Wells Fargo Securities Healthcare Conference

DUBLIN, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 14th Annual Wells Fargo Securities Healthcare Conference on Thursday, September 5, 2019, in Boston.

Medtronic Names Geoffrey Martha as CEO, Replacing Omar Ishrak

Medtronic Names Geoffrey Martha as CEO, Replacing Omar Ishrak

The medical device company says Geoffrey Martha will take over as CEO in April 2020.

Medtronic Announces Planned Leadership Succession

Medtronic Announces Planned Leadership Succession

Omar Ishrak Will Retire as CEO at End of Fiscal Year;  Remains Chairman of the Board and Becomes Executive Chairman of Medtronic  Geoff Martha, EVP of the Restorative Therapies Group, Appointed Medtronic President, and Will Join the Medtronic Board of...

Medtronic Announces Cash Dividend For Second Quarter Of Fiscal Year 2020

Medtronic Announces Cash Dividend For Second Quarter Of Fiscal Year 2020

DUBLIN, Aug. 23, 2019 (GLOBE NEWSWIRE) -- The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2020 second quarter cash dividend of $0.

Medtronic Rises as Heart Device Maker Pumps Out Revenue Beat

Medtronic Rises as Heart Device Maker Pumps Out Revenue Beat

Medtronic's cardiac and vascular unit generates $2.79 billion in fiscal first-quarter revenue, surpassing analysts' estimates.

Profit Taking, Rate Cuts and a Play on Zscaler: Market Recon

Profit Taking, Rate Cuts and a Play on Zscaler: Market Recon

Evaluating the market and policy discussion ahead of Jackson Hole, and how I am playing Zscaler on this weakness.

Medtronic Reports First Quarter Financial Results

Medtronic Reports First Quarter Financial Results

Revenue of $7.5 Billion Increased 1.

Medtronic Evolut TAVR System Receives Expanded Indication To Treat Symptomatic Severe Aortic Stenosis Patients At Low Risk For Surgical Mortality

Medtronic Evolut TAVR System Receives Expanded Indication To Treat Symptomatic Severe Aortic Stenosis Patients At Low Risk For Surgical Mortality

Expanded TAVR Indication to Younger, More Active Patients Signals Groundbreaking Shift in the Future Treatment of Heart Valve Disease

Medtronic Approved To Start Pivotal Trial To Evaluate New Extended Wear Infusion Set

Medtronic Approved To Start Pivotal Trial To Evaluate New Extended Wear Infusion Set

Experimental Infusion Set Aims to Address Patient Burden with Comfort and Convenience Features for Insulin Pump Therapy

Medtronic To Announce Financial Results For Its First Quarter Of Fiscal Year 2020

Medtronic To Announce Financial Results For Its First Quarter Of Fiscal Year 2020

DUBLIN, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for the first quarter of fiscal year 2020 on Tuesday, August 20, 2019.

Real Money Post-Industrial Average Leads Major Indexes So Far for Year

Real Money Post-Industrial Average Leads Major Indexes So Far for Year

In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.

Medtronic Requests Approval Of Non-Adjunctive Labeling From FDA

Medtronic Requests Approval Of Non-Adjunctive Labeling From FDA

DUBLIN, July 23, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced its Premarket Approval (PMA) submission to the U.

Medtronic Partners With Viz.ai To Accelerate Adoption Of New Artificial Intelligence Software In U.S. Stroke Centers

Medtronic Partners With Viz.ai To Accelerate Adoption Of New Artificial Intelligence Software In U.S. Stroke Centers

Technology Has the Potential to Save Crucial Time and Increase Access to Lifesaving Stroke Treatments

Medtronic Announces The Early Results Of Its Cash Tender Offers For Up To $5.525 Billion Of Certain Outstanding Debt Securities Issued By Medtronic, Inc., Medtronic Global Holdings S.C.A. And Covidien International Finance S.A.

Medtronic Announces The Early Results Of Its Cash Tender Offers For Up To $5.525 Billion Of Certain Outstanding Debt Securities Issued By Medtronic, Inc., Medtronic Global Holdings S.C.A. And Covidien International Finance S.A.

DUBLIN, July 10, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (the "Company") (NYSE:MDT) today announced that, pursuant to the previously announced cash tender offers (collectively, the "Tender Offers") by its wholly-owned indirect subsidiaries, Medtronic, Inc.

Medtronic HeartWare(TM) HVAD(TM) Implanted Via Less Invasive Thoracotomy Shows 95 Percent Freedom From Disabling Stroke At Two Years

Medtronic HeartWare(TM) HVAD(TM) Implanted Via Less Invasive Thoracotomy Shows 95 Percent Freedom From Disabling Stroke At Two Years

Company Plans Global Registry of HVAD Thoracotomy Implants to Advance Therapy Knowledge

Medtronic Announces Closing Of Public Offering Of €5 Billion Of Senior Notes

Medtronic Announces Closing Of Public Offering Of €5 Billion Of Senior Notes

DUBLIN, July 02, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (the "Company") (NYSE:MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.

Amgen's Rally Could Just Be Getting Started

Amgen's Rally Could Just Be Getting Started

Amgen shares have rallied in recent years. Dividend growth names like Amgen remain attractive in a low-yield environment. Healthcare will likely continue in the headlines.

Dexcom Looks Like It Can Finally Break Out on the Topside

Dexcom Looks Like It Can Finally Break Out on the Topside

Let's check the charts and indicators on the glucose-monitoring company.

The Barbell Economy: Cramer's 'Mad Money' Recap (Thursday 6/13/19)

The Barbell Economy: Cramer's 'Mad Money' Recap (Thursday 6/13/19)

Jim Cramer looks at retail, specifically the companies that are doing well for working-class Americans, and those that cater to high-end customers -- a 'barbell economy,' he says.

TheStreet Quant Rating: A (Buy)